PRTN3 and rheumatoid arthritis: The association of an increased risk of future CVE mainly in the ACPA-positive patients at baseline could be due to this population’s higher inflammatory profile and could imply that ACPA-positive RA is a more severe disease, with potentially more comorbidity such as CVD, than ACPA-negative disease, as has been suggested by others [25].